Research Article
A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients
Table 2
Sociodemographic and general health characteristics.
| | Patient characteristics |
Frequency (percentage) or
mean (range) | | Viscum | Etoposide |
| | Gender | | | | Male | 4 (44.4) | 7 (63.6) | | Female | 5 (55.6) | 4 (39.4) | | Age (years) | 28 (18–48) | 39 (11–66) | | Ethnic group | | | | Caucasian | 8 (88.9) | 11 (100) | | Asian | 1 (11.1) | — | | Family status | | | | Single/divorced | 8 (88.9) | 6 (54.5) | | Married/in partnership | 1 (11.1) | 5 (45.5) | | Highest education | | | | Vocational training | 5 (55.6) | 7 (63.6) | | University graduate/student | 4 (44.4) | 4 (36.5) | | ECOG | | | | 0 | 3 (33.3) | 6 (54.6) | | 1 | 6 (66.7) | 5 (45.4) | | ≥2 | — | — | | Concomitant diseases | 1 (11.1) | 3 (27.3) | | Paget syndrome | — | 1 (11.1) | | HCV | 1 (11.1) | — | | Primary hyperparathyroidism | — | 1 (11.1) | | Kidney tubulopathy | — | 1 (11.1) | | Current regular medication | 5 (55.6) | 6 (54.6) | | Current signs and symptoms | | | | Pain | 2 (22.2) | 1 (9.1) | | Weight loss | 2 (22.2) | 1 (9.1) | | Cough | 1 (11.1) | 1 (9.1) | | Dyspnea | 1 (11.1) | — |
|
|
